| Phase 1 | 1 | |
| Phase 2 | 2 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05626855 | Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous… | Spinal Muscular Atrophy | Active, Not Recruiting | 2026-09-01 |
| Phase 2 | ||||
| NCT07047144 | A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and… | Spinal Muscular Atrophy | Recruiting | 2026-10-02 |
| NCT07435129 | Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD | Facioscapulohumeral Muscular Dystrophy | Recruiting | 2026-09-02 |
| Phase 1 | ||||
| NCT07444294 | A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults | Healthy | Recruiting | 2026-03-02 |